ArticleMedicine2019

Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial.

Jungbin Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.